Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001104659-25-029875
Filing Date
2025-03-31
Accepted
2025-03-31 16:15:44
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 NT 10-K tm2510924d1_nt10k.htm NT 10-K 27647
  Complete submission text file 0001104659-25-029875.txt   28730
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-40363 | Film No.: 25793458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)